Amylyx Nominates AMX0318 as Long-Acting GLP-1 Candidate for Rare Endocrine Disorders

2 weeks ago 8

Maham Fatima

Mon, January 19, 2026 astatine 7:01 AM CST 2 min read

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is 1 of the overlooked maturation stocks to buy. On January 8, Amylyx Pharmaceuticals (NASDAQ:AMLX) announced the information of AMX0318 arsenic its newest improvement candidate. Identified done a strategical collaboration with Gubra A/S, AMX0318 is simply a novel, long-acting glucagon-like peptide-1/GLP-1 receptor antagonist designed to dainty post-bariatric hypoglycemia/PBH and different uncommon diseases.

The improvement of AMX0318 utilized Gubra’s proprietary streaMLine platform, which is an AI-driven exertion utilized to optimize peptide candidates. Amylyx plans to initiate IND-enabling studies for AMX0318 aboriginal successful 2026, with a people of filing an IND exertion successful 2027. This caller programme complements Amylyx’s existing pb candidate, avexitide, which is presently being evaluated successful the pivotal Phase 3 LUCIDITY proceedings for PBH. The institution expects to decorativeness recruitment for the LUCIDITY proceedings successful Q1 2026 and anticipates a topline information readout successful Q3 2026.

Amylyx Nominates AMX0318 arsenic Long-Acting GLP-1 Candidate for Rare Endocrine Disorders

Earlier connected December 19, Bank of America lowered the firm’s terms people connected Amylyx to $15 from $16, portion keeping a Buy standing connected the shares. Following Amylyx’s Q3 2025 net report, the steadfast highlighted that caller financing secured the company’s currency runway done 2028. BofA noted that the stock’s superior catalyst remains the Phase 3 LUCIDITY proceedings for avexitide. Data from this pivotal study, which targets post-bariatric hypoglycemia, is expected successful Q3 2026.

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is simply a clinical-stage pharmaceutical institution that discovers and develops attraction options for neurodegenerative diseases and endocrine conditions successful the US.

While we admit the imaginable of AMLX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.